Our finding that Arsb is a target of miR-154-5p and participates in the development of cardiomyocyte hypertrophy is important, consistent with the cardiac pathological phenomena in patients with MPS VI. The gene discussed is ARSB; the disease is mucopolysaccharidosis type 6.